Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France
Authors' conclusion
This study emphasizes the value of the FSL system in reducing ADEs in people with T2DM in France not on intensive insulin therapy and initially treated with basal-only insulin therapy.
Study context
- Population
- People with T2D on basal insulin only ± noninsulin antidiabetic drugs with first FSL reimbursement between August 1, 2017 and December 31, 2018, France; 78.9% on basal insulin and other hypoglycemic agents
- Participants
- 5,933 people
- Exposure
- After vs before FreeStyle Libre initiation
- Outcome
- Hospitalizations for acute diabetes events (SH, DKA, comas, hyperglycemia-related admissions; ICD-10 codes)
Methodological detailsbefore–after comparison, French national claims database (Système National des Données de Santé)
- Before–after comparison
- French national claims database (Système National des Données de Santé)
Main finding
As reported in the abstract
≥1 hospitalization for any ADE
| Group | Value | At 2 years |
|---|---|---|
| Before FSL | 2.01% | |
| After FSL | 0.75% | 0.60% |
Value
Before FSL2.01%
After FSL0.75%
At 2 years
Before FSL— not stated in the abstract
After FSL0.60%
- Reduction in diabetic ketoacidosis (DKA) admissions
- 75%
- Reduction in severe hypoglycemia (SH) admissions
- 44%
Observational data: associations, not effects.
Further findings
DKA rates after 2 years
- Further reduction in DKA rates
- 43%
Original publication
Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France. Diabetes Technol Ther. Published 24 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →